HOMEwww.epgonline.orgDRUGSwww.epgonline.orgDISEASE KNOWLEDGEwww.epgonline.orgGUIDELINESwww.epgonline.orgCLINICAL TRIALSwww.epgonline.orgREGISTERwww.epgonline.orgSEARCH
Members
Why a doctor should
Username/Email

Password ()




EPG on Twitter EPG Online Twitter
EPG Online Blog EPG Online Blog
EPG Online Disease Knowledge Centres Feed Disease Knowledge
Recent UK Drug Updates Drug Updates
EPG Search
Search
Languages

YUTOPAR overview

Yutopar Tablets: Follow-on to Yutopar

Tablets: Follow-on to parenteral therapy to maintain uterine quiescence.

Yutopar: Uncomplicated preterm labour between 24 - 33 weeks gestation. To delay delivery to enable glucocorticosteroids or other measures to be used.

banner_pass = 1

Please register to access disease diagnosis, patient management, physician tools.
By viewing the content of this web page you are both confirming your status as a healthcare professional and agreeing to our terms of use.

Change language Current language database: English
 
 
Related DrugsDrug Details
YUTOPAR
Drug Class Description :

b-agonists (beta-agonists, beta- adrenoceptor stimulants).

Generic Name :

Ritodrine

Drug description :

Yutopar Tablets: yellow, scored tablet marked YUTOPAR. Yutopar: ampoule.

Presentation :

Yutopar Tablets: Ritodrine hydrochloride 10 mg . Yutopar: Ritodrine hydrochloride 10 mg /mL.

Indications :

Yutopar Tablets: Follow-on to Yutopar

Tablets: Follow-on to parenteral therapy to maintain uterine quiescence.

Yutopar: Uncomplicated preterm labour between 24 - 33 weeks gestation. To delay delivery to enable glucocorticosteroids or other measures to be used.

Adult Dosage :

Yutopar Tablets: 1 approximately 30 minutes before termination of intravenous therapy. Maintenance: 1 two hourly for 24 hours, then 1 or 2 four to six hourly.

Yutopar: Initially 50 microgram/ minute intravenously in 5% dextrose solution, increase gradually until control. Usual range, 150 - 350 microgram/ minute. Continue infusion for 12 - 48 hours after contractions have stopped. Use a syringe pump to reduce fluid overload.

Child Dosage :

Not applicable.

Contra Indications :

Antepartum haemorrhage, eclampsia, pre-eclampsia, cord compression, foetal death, chorioamnionitis, maternal cardiac disease.

Special Precautions :

Avoid fluid overload; keep intravenous fluids to minimum and monitor maternal hydration. Multiple pregnancy, suspected cardiovascular disease, maternal infection, hyperthyroidism, hypertension, diabetes. Monitor maternal and foetal heart rate.

Interactions :

MAOIs, tricyclic antidepressants, corticosteroids, sympathomimetics, anaesthetics, K+-depleting diuretics, b- blockers.

Adverse Reactions :

Maternal pulmonary oedema (withdraw drug immediately and institute diuretic therapy). Tachycardia, flushing, sweating, nausea, chest pain, arrhythmia, vomiting, rise in blood sugar, tremor, leucopenia and/or agranulocytosis, impaired liver function, raised liver transaminases, enlarged salivary glands, increased amylase

Manufacturer :

Solvay

Drug Availability :

(POM)

Drug Updated :

17 June 2009

Related Drugs - Obstetrics
Soft Tissue Sarcoma Alzheimer's disease (AD) is a progressive, neurodegenerative disease which will affect most of us at one point in time, and it’s prevalence increases with age. Opioid and Pain Management - understanding, management, diagnosis and treatment information Cystic Fibrosis
New and updated Drugs
UK Drugs EPG Medical News Feed
Spanish Drugs EPG Medical News Feed
German Drugs EPG Medical News Feed
Norweigan Drugs EPG Medical News Feed
Netherlands Drugs EPG Medical News Feed
Swedish Drugs EPG Medical News Feed
French Drugs EPG French Drugs Feed
Portuguese Drugs EPG Portuguese Drugs Feed
Italian Drugs EPG Italian Drugs Feed

Atopic Dermatitis

Atopic Dermatitis

CONNECT

DISEASE CENTRES Disease Centres feed

AFFILIATE PARTNERS

QUICK SEARCH

GUIDELINES UK Drug Data Feed

DRUG DATA UK Drug Data Feed

REFERENCES